Skip to main content

Changes in haemostasis during normal pregnancy: does homocysteine play a role in maintaining homeostasis?

  • Valerie A. Holmes (a1)

Homocysteine, derived from the demethylation of the ammo acid methionine, is either further catabolised by trans-sulfuration to cysteine or remethylated to methionine. Remethylation to methionine requires the cofactors, folate and vitamin B12. Folate is an effective homocysteine-lowering agent and, thus, homocysteine and folate status are inversely related. Hyperhomocysteinaemia is a strong independent risk factor for venous thromboembolism (VTE) and is associated with adverse pregnancy outcomes such as pre-eclampsia, placental abruption, early pregnancy loss and neural-tube defects. Pregnancy is a risk factor for VTE as a result of prothrombotic changes in levels of haemostatic factors. However, despite this hypercoagulable state, the incidence of pregnancy-associated VTE is relatively low. Hyperhomocysteinaemia is associated with abnormalities in markers of coagulation activation, and recent research suggests that folic acid supplementation, as well as lowering homocysteine, lowers markers of coagulation activation and increases levels of coagulation inhibitors. Tissue factor (TF) is the initiator of blood coagulation in vivo, and homocysteine induces TF expression in vitro. During pregnancy, monocyte TF expression is lower than that in the non-pregnant state, and this lowering of TF may act to counterbalance increases in coagulation activation. Furthermore, despite a high folate requirement, several studies have reported that homocysteine is lower in normal pregnancy than in the non-pregnant state. Although the exact mechanism of homocysteine lowering during pregnancy is unclear, one possible outcome of lower homocysteine may be the protection of women from pregnancy complications and VTE, and thus lower homocysteine may contribute to maintaining homeostasis in haemostasis.

    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Changes in haemostasis during normal pregnancy: does homocysteine play a role in maintaining homeostasis?
      Available formats
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Changes in haemostasis during normal pregnancy: does homocysteine play a role in maintaining homeostasis?
      Available formats
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Changes in haemostasis during normal pregnancy: does homocysteine play a role in maintaining homeostasis?
      Available formats
Corresponding author
Corresponding author: Dr Valerie Holmes, Present address: Department of Medicine, Queen's University Belfast, Mulhouse, Grosvenor Road, Belfast BT12 6BJ, UK, fax +44 2890 235900,
Hide All
Alhenc-Gelas M, Arnaud E, Nicaud V, Aubry ML, Fiessinger JN, Aiach M & Emmerich J (1999) Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes. Thrombosis and Haemostasis 81, 506510
Al-Obaidi MK, Philippou H, Stubbs PJ, Adami A, Amersey R, Noble MM & Lane DA (2000) Relationships between homocysteine, factor VIIa, and thrombin generation in acute coronary syndromes. Circulation 101, 372377
Andersson A, Brattström L, Israelsson B, Isaksson A, Hamfelt A & Hultberg B (1992a) Plasma homocysteine before and after methionine loading with regard to age, gender and menopausal status. European Journal of Clinical Investigation 22, 7987
Andersson A, Hultberg B, Brattstrom L & Isaksson A (1992b) Decreased serum homocysteine in pregnancy. European Journal of Clinical Chemistry and Clinical Biochemistry 30, 377379
Bauer KA (1999) Activation markers of coagulation. Bailliere's Best Practice and Research in Clinical Haematology 12, 387406
Becker A, van Hinsbergh, VW Kostense, PJ Jager, A Dekker, JM Nijpels, G Heine, RJ Bouter, LM Stehouwer CD (2000) Serum homocysteine is weakly associated with von Willebrand factor and soluble vascular cell adhesion molecule 1, but not with C-reactive protein in type 2 diabetic and non-diabetic subjects–The Hoorn Study. European Journal of Clinical Investigation 30, 763770
Bellart J, Gilabert R, Anglès A, Piera V, Miralles RM, Monasterio J & Cabero L (1999) Tissue factor levels and high ratio of fibrinopeptide A:D-dimer as a measure of endothelial pro-coagulant disorder in pre-eclampsia. British Journal of Obstetrics and Gynaecology 106, 594597
Bellart J, Gilabert R, Fontcuberta J, Borrell M, Miralles RM & Cabero L (1997) Levels of coagulation inhibitors and thromin-antithrombin III complexes in normal pregnancy. Medical Science Research 25, 699702
Bellart J, Gilabert R, Miralles RM, Monasterio J & Cabero L (1998) Endothelial cell markers and fibrinopeptide A to D-dimer ratio as a measure of coagulation and fibrinolysis balance in normal pregnancy. Gynecologic and Obstetric Investigation 46, 1721
Bernstein IM, Ziegler W & Badger GJ (2001) Plasma volume expansion in early pregnancy. Obstetrics and Gynecology 9, 669672
Bienvenu T, Ankri A, Chadefaux B, Montalescot G & Kamoun P (1993) Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters. Thrombosis Research 70, 123129
Bienvenu T, Chadefaux B, Ankri A, Leblond V, Coude M, Salehian B, Binet JL & Kamoun P (1991) Antithrombin III activity is not related to plasma homocysteine concentrations. Haemostasis 21, 6567
Blombäck M (1991) Changes in blood coagulation and fibrinolysis during pregnancy and the menstrual cycle: new methods for detecting the changes. Advances in Contraception 7, 259S272S
Bokarewa MI, Wramsby M, Bremme K & Blomback M (1997) Variability of the response to activated protein C during normal pregnancy. Blood Coagulation and Fibrinolysis 8, 239244
Bonnette RE, Caudill MA, Boddie AM, Hutson AD, Kauwell GPA & Bailey LB (1998) Plasma homocyst(e)ine concentration in pregnant and non-pregnant women with controlled folate intake. Obstetrics and Gynecology 92, 167170
Božič M, Stegnar M, Fermo I, Ritonja A, Peternel P, Stare J, D'Angelo A (2000) Mild hyperhomocysteinemia and fibrinolytic factors in patients with history of venous thromboembolism. Thrombosis Research 100, 271278
Brattström L, Israelsson B, Tengborn L & Hultberg B (1989) Homocysteine, factor VII and antithrombin III in subjects with different gene dosage for cystathionine beta-synthase. Journal of Inherited Metabolic Disease 12, 475482
Brattstrom L, Wilcken DEL, Öhrvik J & Brudin L (1998) Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease–the result of a meta-analysis. Circulation 98, 25202526
Bremme K, Ostlund E, Almqvist I, Heinonen K, Blombäck M (1992) Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstetrics and Gynaecology 80, 132137
Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z & Lanir N (1999) Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thrombosis and Haemostasis 82, 69
Bronstrup A, Hages M, Prinz-Langenohl R & Pietrzik K (1998) Effects of folic acid and combinations of folic acid and vitamin B-12 on plasma homocysteine concentrations in healthy, young women. American Journal of Clinical Nutrition 68, 11041110
Brunelli T, Frisco D, Fedi S, Rogolino A, Farsi A, Marcucci R, Giusti B, Pratesi C, Pulli R, Gensini GF, Abbate R & Pepe G (2000) High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. Journal of Vascular Surgery 32, 531536
Cattaneo M, Franchi F, Maddalena ZL, Martinelli I, Asti D & Mannucci PM (1998) Plasma levels of activated protein C in healthy subjects and patients with previous venous thromboembolism. Relationships with plasma homocysteine levels. Arteriosclerosis, Thrombosis and Vascular Biology 18, 13711375
Cermak J, Key NS, Bach RR, Balla J, Jacob HS & Vercellotti GM (1993) C-reactive protein induces human peripheral blood monocytes to synthesise tissue factor. Blood 82, 513520
Cerneca F, Ricci G, Simeone R, Malisano M, Alberico S & Guaschino S (1997) Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hyper-coagulable state, combined with a reactive fibrinolysis. European Journal of Obstetrics and Gynaecology and Reproductive Biology 73, 3136
Chan LY, Tarn WH & Lau TK (2001) Venous thromboembolism in pregnant Chinese women. Obstetrics and Gynecology 98, 471475
Chan SY, Chan PH, Ho PC & Yam A (1985) Factor VIII-related antigen levels in normal pregnancy and puerperium. European Journal of Obstetrics and Gynaecology and Reproductive Biology 19, 199204
Chanarin I (1985) Folate and cobalamin. Clinical Haematology 14, 629641
Clark P, Brennand J, Conkie JA, McCall F, Greer IA & Walker ID (1998) Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thrombosis and Haemostasis 79, 11661170
Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB & Semerara N (1983) Cultured human endothelial cells generate tissue factor in response to endotoxin. Journal of Clinical Investigation 71, 18931896
Comeglio P, Fedi S, Liotta AA, Cellai AP, Chiarantini E, Prisco D, Mecacci F, Parretti E, Mello G & Abbate R (1996) Blood clotting activation during pregnancy. Thrombosis Research 84, 199202
Comp PC, Thurnau GR, Welsh J & Esmon CT (1986) Functional and immunologic protein S levels are decreased during pregnancy. Blood 68, 881885
Confidential Enquiries, into Maternal Deaths (2000) Why Mothers Die 19971999. The Fifth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom London Royal College of Obstetricians and Gynaecologists
Constans J, Blann AD, Resplandy F, Parrot F, Renard M, Seigneur M, Guérin V, Boisseau M & Conri C (1999) Three months supplementation of hyperhomocysteinaemic patients with folic acid and vitamin B6 improves biological markers of endothelial dysfunction. British Journal of Haematology 107, 776778
Cotter AM, Molloy AM, Scott JM & Daly SF (2001) Elevated plasma homocysteine in early pregnancy: A risk factor for the development of severe pre-eclampsia. American Journal of Obstetrics and Gynecology 185, 781785
Couturaud F, Oger E, Abalain JH, Chenu E, Guias B, Floch HH, Mercier B, Mottier D & Leroyer C (2000) Methylenetetrahydro-folate reductase C677T genotype and venous thromboembolic disease. Respiration 67, 657661
Cumming AM, Tail RC, Fildes S, Yoong A, Keeney S & Hay CR (1995) Development of resistance to activated protein C during pregnancy. British Journal of Haematology 90, 725727
Czeizel AE & Dudas I (1992) Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. New England Journal of Medicine 327, 18321835
Davie EW & Ratnoff OD (1964) Waterfall sequence for intrinsic blood clotting. Science 145, 13101312
Dekker GA, de Vries, JIP Doelitzsch, PM Huijgens, PC von, Blomberg BME, Jakobs C, van Geijn HP (1995) Underlying disorders associated with severe early-onset pre-eclampsia. American Journal of Obstetrics and Gynecology 173, 10421048
D'Elia AV, Driul L, Giacomello R, Colaone R, Fabbro D, Di Leonardo, C Florio, P Petraglia, F Marchesoni, D Damante G (2002) Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase in pre-eclampsia. Gynecologic and Obstetric Investigation 53, 8487
de Jong, SC Stehouwer, CD van den, Berg M, Vischer UM, Rauwerda JA & Emeis JJ (1997) Endothelial marker proteins in hyperhomocysteinemia. Thrombosis and Haemostasis 78, 13321337
de Moerloose, P Amiral, J Vissac, AM Reber G (1998a) Longitudinal study on activated factors XII and VII levels during normal pregnancy. British Journal of Haematology 100, 4044
de Moerloose, P Mermillod, N Amiral, J Reber G (1998b) Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1. Thrombosis and Haemostasis 79, 554556
den Heijer, M Koster, T Blom, HJ Bos, GMJ Briët, E Reitsma, PH Vandenbroucke, JP Rosendaal FR (1996) Hyperhomo-cysteinemia as a risk factor for deep-vein thrombosis. New England Journal of Medicine 334, 759762
Department of Health (1992) Report from an Expert Advisory Group. Folic Acid and the Prevention of Neural Tube Defects London Department of Health
de Valk-de, Roo GW, Stehouwer CD, Lambert J, Schalkwijk CG, van der, Mooren MJ, Kluft C & Netelenbos C (1999) Plasma homocysteine is weakly correlated with plasma endothelin and von Willebrand factor but not with endothelium-dependent vasodilatation in healthy postmenopausal women. Clinical Chemistry 45, 12001205
de Vries, JIP Dekker, GA Huijgens, PC Jakobs, C Blomberg, BME van Geijn H P (1997) Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies. British Journal of Obstetrics and Gynaecology 104, 12481254
Dimitrova KR, DeGroot K, Myers AK & Kim YD (2002) Estrogen and homocysteine. Cardiovascular Research 53, 577588
Donohoe S, Quenby S, Mackie I, Panal G, Farquharson R, Malia R, Kingdom J & Machin S (2002) Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies. Lupus 11, 1120
Douglas JT, Shah M, Lowe GDO, Belch JJF, Forbes CD & Prentice CRM (1982) Plasma fibrinopeptide A and beta-thromboglobulin in pre-eclampsia and pregnancy hypertension. Thrombosis and Haemostasis 47, 5455
Drake TA, Morrissey JH & Edgington TS (1989) Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. American Journal of Pathology 134, 10871097
Durand P, Lussier-Cacan S & Blache D (1997) Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats. FASEB Journal 11, 11571168
Eichinger S, Stümpflen A, Hirschl M, Bialonczyk C, Herkner K, Stain M, Schneider B, Pabinger I, Lechner K & Kyrle PA (1998) Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism. Thrombosis and Haemostasis 80, 566569
Eichinger S, Welttermann A, Phillip K, Hafner E, Kaider A, Kittl E, Brenner B, Mannhalter C, Lechner K & Kyrle PA (1999) Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thrombosis and Haemostasis 82, 12321236
Estelles A, Gilabert J, Anznar J, Loskutoff DJ & Schleef RR (1989) Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe pre-eclampsia. Blood 74, 13321338
Falcon CR, Cattaneo M, Panzeri D, Martinelli I & Mannucci PM (1994) High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. Arteriosclerosis and Thrombosis 14, 10801083
Faught W, Garner P, Jones G & Ivey B (1995) Changes in protein C and protein S levels in normal pregnancy. American Journal of Obstetrics and Gynecology 172, 147150
Fernandez JA, Estelles A, Gilabert J, Espana F & Aznar J (1989) Functional and immunologic protein S in normal pregnant women and in full-term newborns. Thrombosis and Haemostasis 61, 474478
Finkelstein JD (2000) Pathways and regulation of homocysteine metabolism in mammals. Seminars in Thrombosis and Haemostasis 26, 219225
Foka ZJ, Lambropoulos AF, Saravelos H, Karas GB, Karavida A, Agorastos T, Zournatzi V, Makris PE, Bontis J & Kotsis A (2000) Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriage. Human Reproduction 15, 458462
Folsom AR, Nieto FJ, McGovern PG, Tsai MY, Malinow MR, Eckfeldt JH, Hess DL & Davis CE (1998) Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins–The Atherosclerosis Risk in Communities (ARIC) study. Circulation 98, 204210
Francalanci I, Comeglio P, Liotta AA, Cellai AP, Fedi S, Parretti E, Mello G, Prisco D & Abbate R (1995) D-dimer concentrations during normal pregnancy, as measured by ELISA. Thrombosis Research 78, 399405
Freyburger G, Labrouche S, Sassoust G, Rouanet F, Javorschi S & Parrot F (1997) Mild hyperhomocysteinemia and hemostatic factors in patients with arterial vascular diseases. Thrombosis and Haemostasis 77, 466471
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer, M Kluijtmans, LAJ van den, Heuvel LP & Rozen R (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics 10, 111113
Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA & Rodgers GM (1993) Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arteriosclerosis and Thrombosis 13, 13271333
Gatti L, Tenconi PM, Guarneri D, Bertulessi C, Ossola MW, Bosco P & Gianotti GA (1994) Hemostatic parameters and platelet activation by flow-cytometry in normal pregnancy: a longitudinal study. International Journal of Clinical and Laboratory Research 24, 217219
Gemmati D, Previati M, Serino ML, Moratelli S, Guerra S, Capitani S, Forini E, Ballerini G & Scapoli GL (1999a) Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocysteinemia in normal and thromboembolic subjects. Arteriosclerosis, Thrombosis and Vascular Biology 19, 17611767
Gemmati D, Serino ML, Trivellato C, Fiorini S & Scapoli GL (1999b) C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients. Haematologica 84, 824828
George JN (2000) Platelets. Lancet 355, 15311539
Gerbasi FR, Bottoms S, Farag A & Mammem E (1990) Increased intravascular coagulation associated with pregnancy. Obstetrics and Gynecology 75, 385389
Gharavi AE, Pierangeli SS, Levy RA & Harris EN (2001) Mechanism of pregnancy loss in antiphospholipid syndrome. Clinical Obstetrics and Gynecology 44, 1119
Gherman RB, Goodwin TM, Leung B, Byrne JD, Hethumumi R & Montoro M (1999) Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstetrics and Gynecology 94, 730734
Goddijn-Wessel TAW, Wouters MGAJ, van der, Molen EF, Spuijbroek MDEH, Steegers-Theunissen RPM, Blom HJ, Boers GHJ & Eskes TKAB (1996) Hyperhomocysteinemia: a risk factor for placental abruption or infarction. European Journal of Obstetrics and Gynecology and Reproductive Biology 66, 2329
Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P, Montanaro S, Pavone G, Di Minno G (1997) Factor V Leiden, C>T MTHFR polymorphism and genetic susceptibility to pre-eclampsia. Thrombosis and Haemostasis 77, 10521054
Grandone E, Margaglione M, Colaizzo D, D'Andrea G, Cappucci G, Brancaccio V, Di Minno G (1998) Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. American Journal of Obstetrics and Gynecology 179, 13241328
Greer IA (1994) Haemostasis and thrombosis in pregnancy Haemostasis and Thrombosis 3rd ed. 9871015 Bloom AL Forbes CD Thomas DP Tuddenham EGD Edinburgh Churchill Livingstone
Greer IA (1999) Thrombosis in pregnancy: maternal and fetal issues. Lancet 353, 12581265
Greer IA (2001) Procoagulant microparticles: new insights and opportunities in pregnancy loss?. Thrombosis and Haemostasis 85, 34
Gris JC, Quere I, Monpeyroux F, Mercier E, Ripart-Neveu S, Tailland ML, Hoffet M, Berlan J, Daures JP & Mares P (1999) Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent–the Nimes Obstetricians and Haematologists study 5 (NOHA5). Thrombosis and Haemostasis 81, 891899
Hajjar KA (1993) Homocysteine-induced modulation of tissue plasminogen activator to its endothelial cell membrane receptor. Journal of Clinical Investigation 91, 28732879
Hajjar KA & Jacovina AT (1998) Modulation of anexin II by homocysteine: implications for atherothrombosis. Journal of Investigative Medicine 46, 364369
Hayashi T, Honda G & Suzuki K (1992) An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells. Blood 79, 29302936
Hellgren M, Blombäck M (1981) Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puer-perium. Gynecologic and Obstetric Investigation 12, 141154
Hemker HC & Beguin S (1995) Thrombin generation in plasma: its assessment via the endogenous thrombin potential. Thrombosis and Haemostasis 74, 134138
Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Admiral J, Schmidt AM, Fiehn W, Ziegler R, Wahl P & Nawroth PP (1998) Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care 21, 841848
Holmes VA, Wallace JMW, Gilmore WS, McFaul P & Alexander HD (2002) Tissue factor expression on monocyte subpopulations during normal pregnancy. Thrombosis and Haemostasis 87, 953958
Homocysteine Lowering, Trialists' Collaboration (1998) Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. British Medical Journal 316, 894898
Hutton RA, Laffan MA & Tuddenham EGD (1999) Normal haemostasis Postgraduate Haematology 4th ed. 550580 Hoffbrand AV Lewis SM Tuddenham EDG Oxford Butterworth Heinemann
Kaiser T, Brennecke SP & Moses EK (2001) C677T methylene-tetrahydrofolate reductase polymorphism is not a risk factor for pre-eclampsia/eclampsia among Australian women. Human Heredity 51, 2022
Kang SS, Wong PWK & Norusis M (1987) Homocysteinemia due to folate deficiency. Metabolism 36, 458462
Kang SS, Wong PWK, Zhou J & Cook HY (1986) Total homocyst(e)ine in plasma and amniotic fluid of pregnant women. Metabolism 35, 889891
Kario K, Duell PB, Matsuo T, Sakata T, Kato H, Shimada K & Miyata T (2001) High plasma homocyst(e)ine levels in elderly Japanese patients are associated with increased cardiovascular disease risk independently from markers of coagulation activation and endothelial cell damage. Atherosclerosis 157, 441449
Khajuria A & Houston DS (2000) Induction of monocyte tissue factor expression by homocysteine: a possible mechanism for thrombosis. Blood 96, 966972
Kjellberg U, Andersson NE, Rosén S, Tengborn L & Hellgren M (1999) APC resistance and other haemostatic variables during pregnancy and puerperium. Thrombosis and Haemostasis 81, 527531
Kluijtmans LAJ, den Heijer, M Reitsma, PH Heil, SG Blom, HJ Rosendaal FR (1998) Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis. Thrombosis and Haemostasis 79, 254258
Kristensen B, Malm J, Nilsson TK, Hultdin J, Carlberg B, Dahlen G & Olsson T (1999) Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke. Stroke 30, 974980
Kuch B, Bobak M, Fobker M, Junker R, von Eckardstein, A Marmot, M Hense HW (2001) Associations between homocysteine and coagulation factors–a cross-sectional study in two populations of Central Europe. Thrombosis Research 103, 265273
Kunz K, Petitjean P, Lisri M, Chantrel F, Koehl C, Wiesel ML, Cazenave JP, Moulin B & Hannedouche TP (1999) Cardio-vascular morbidity and endothelial dysfunction in chronic haemodialysis patients: is homocyst(e)ine the missing link?. Nephrology Dialysis Transplantation 14, 19341942
Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G & Lessing JB (1999) Increased frequency of genetic thrombophilia in women with complications of pregnancy. New England Journal of Medicine 340, 913
Laude I, Rongières-Bertrand C, Boyer-Neumann C, Wolf M, Mairovitz V, Hugel B, Freyssinet JM, Frydman R, Meyler D, Eschwège V (2001) Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight. Thrombosis and Haemostasis 85, 1821
Lentz SR & Sadler JE (1991) Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. Journal of Clinical Investigation 88, 19061914
Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR & Heistad DD (1996) Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. Journal of Clinical Investigation 98, 2429
Lindgren A, Lindoff C, Norrving B, Astedt B & Johansson BB (1996) Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients. Stroke 27, 10661071
Lindqvist P, Dahlbäck B, Maršál K (1999) Thrombotic risk during pregnancy: a population study. Obstetrics and Gynecology 94, 595599
Ling Q & Hajjar KA (2000) Inhibition of endothelial cell thromboresistance by homocysteine. Journal of Nutrition 130, 373S376S
Lyall F & Greer IA (1996) The vascular endothelium in normal pregnancy and pre-eclampsia. Reviews of Reproduction 1, 107116
McColl MD, Ellison J, Reid F, Tail RC, Walker ID & Greer IA (2000) Prothrombin 20210 G→A, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancy. British Journal of Obstetrics and Gynaecology 107, 565569
McColl MD, Ramsay JE, Tail RC, Walker ID, McCall F, Conkie JA, Carty MJ & Greer IA (1997) Risk factors for pregnancy associated venous thromboembolism. Thrombosis and Haemostasis 78, 11831188
McColl MD, Walker ID & Greer IA (1999) The role of inherited thrombophilia in venous thromboembolism associated with pregnancy. British Journal of Obstetrics and Gynaecology 106, 756766
McKinley MC, McNulty H, McPartlin J, Strain JJ, Pentieva K, Ward M, Weir DG & Scott JM (2001) Low dose vitamin B-6 effectively lowers fasting homocysteine in healthy elderly persons who are folate and riboflavin replete. American Journal of Clinical Nutrition 73, 759764
McPartlin J, Halligan A, Scott JM, Darling M & Weir DG (1993) Accelerated folate breakdown in pregnancy. Lancet 34, 148149
Macfarlane RG (1964) An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 202, 498499
Macklon NS & Greer IA (1996) Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience. Scottish Medical Journal 41, 8386
Macklon NS, Greer IA & Bowman AW (1997) An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy. British Journal of Obstetrics and Gynaecology 104, 191197
Malinow MR, Rajkovic A, Duell PB, Hess DL & Upson BM (1998) The relationship between maternal and neonatal umbilical cord plasma homocyst(e)ine suggests a potential role for maternal homocyst(e)ine in fetal metabolism. American Journal of Obstetrics and Gynecology 178, 228233
Malm J, Laurell M & Dahlback B (1988) Changes in the plasma levels of vitamin K-dependent proteins C and S and of C4b-binding protein during pregnancy and oral contraception. British Journal of Haematology 68, 437443
Many A, Schreiber L, Rosner S, Lessing JB, Eldor A & Kupferminc MJ (2001) Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia. Obstetrics and Gynecology 98, 10411044
Marcucci R, Fedi S, Brunelli T, Pepe G, Prisco D, Rosait A, Zanazzi M, Bertoni E, Abbate R & Salvador M (2001) High cysteine levels in renal transplant recipients: relationship with hyperhomocysteinemia and 5,10-MTHFR polymorphism. Transplantation 27, 746751
Marcucci R, Frisco D, Brunelli T, Pepe G, Gori AM, Fedi S, Capanni M, Simotetti I, Federici G, Pastore A, Abbate R & Gensini GF (2000) Tissue factor and homocysteine levels in ischemic heart disease are associated with angiographically documented clinical recurrences after coronary angioplasty. Thrombosis and Haemostasis 83, 826832
Massouh M, Jatoi A, Gordon EM & Ratnoff OD (1989) Heparin cofactor II activity in plasma during pregnancy and oral contraceptive use. Journal of Laboratory and Clinical Medicine 114, 697699
Mathonnet F, de Mazancourt, P Bastenaire, B Morot, M Benattar, N Beufe, S Borg & JY Giudicelli Y (1996) Activated protein C sensitivity ratio in pregnant women at delivery. British Journal of Haematology 92, 224246
Mayer O, Filipsvský J, Hromádka M, Svobodová V, Racek J, Mayer O, Jr Stehlík, P Trefil, L Zárybnická M (2002) Treatment of hyperhomocysteinemia with folic acid: effects on homocysteine levels, coagulation status, and oxidative stress markers. Journal of Cardiovascular Pharmacology 39, 851857
Mayer O, Jr Šimon, J Rosolová, H Hromádka, M Šubrt, I Vobrubova I (2002) The effects of folate supplementation on some coagulation parameters and oxidative status surrogates. European Journal of Clinical Pharmacology 58, 15
Medical Research Council Vitamin Study Research Group (1991) Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 338, 131137
Midorikawa S, Sanada H, Hashimoto S & Watanabe T (2000) Enhancement by homocysteine of plasminogen activator inhibitor-1 gene expression and secretion from vascular endothelial and smooth muscle cells. Biochemical and Biophysical Research Communications 272, 182185
Mijatovic V, Kenemans P, Jakobs C, van Baal, WM Peters-Muller, ER van der & Mooren MJ (1998a) A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women. Obstetrics and Gynecology 91, 432436
Mijatovic V, Netelenbos C, van der, Mooren MJ, de Valk-de, Roo GW, Jakobs C & Kenemans P (1998b) Randomized, double-blind, placebo controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women. Fertility and Sterility 70, 10851089
Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG & Scott JM (1995) Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345, 149151
Morawitz P (1905) Die Chemie der Blutgerinnung (The chemistry of blood clotting). Ergebnisse der Physiologie 4, 307422
Morris MS, Jacques PF, Selhub J & Rosenberg IH (2000) Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey. American Journal of Epidemiology 152, 140148
Mousa HA & Alfirevicl Z (2000) Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?. Human Reproduction 15, 18301833
Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers GH, Bromberg IL, Cerone R, Fowler B, Grobe H, Schimdt H & Schweitzer L (1985) The natural history of homocystinuria due to cystathionine öβ-synthase deficiency. American Journal of Human Genetics 37, 131
Naruszewicz M, Klinke M, Dziewanowski K, Staniewicz A & Bukowska H (2001) Homocysteine, fibrinogen, and lipoprotein (a) levels are simultaneously reduced in patients with chromic renal failure treated with folic acid, pyridoxine, and cyano-cobalamin. Metabolism 50, 131134
Nelan WLDM, Blom HJ, Steegers EAP, den Heijer, M Thomas, CMG Eskes TKAB (2000) Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstetrics and Gynecology 95, 519524
Nemerson Y (1988) Tissue factor and hemostasis. Blood 71, 18
Neuman F, Ott I, Marx N, Luther T, Kenngott S, Gawaz M, Kotzch M & Schomig A (1997) Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. Arteriosclerosis, Thrombosis and Vascular Biology 17, 33993405
Nishinaga M, Ozawa T & Shimada K (1993) Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. Journal of Clinical Investigation 92, 13811386
Nygård O, Refsum H, Ueland PM, Stensvold I, Nordrehaug JE, Kvale G & Vollset SE (1997) Coffee consumption and plasma total homocysteine: the Hordaland Homocysteine Study. American Journal of Clinical Nutrition 65, 136143
Nygård O, Refsum H, Ueland PM & Vollset SE (1998) Major life-style determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. American Journal of Clinical Nutrition 67, 263270
Nygård O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland PM & Kvale G (1995) Total plasma homocysteine and cardiovascular risk profile: The Hordaland Homocysteine Study. Journal of the American Medical Association 274, 15261533
Øian P, Omsjø I, Maltau JM, Østerud B (1985) Reduced thromboplastin activity in blood monocytes and reduced sensitivity to stimuli in vitro of blood monocytes from pregnant women. British Journal of Haematology 59, 133137
Owen CA (2001) Modern concept of the scheme of blood coagulation A History of Blood Coagulation 1st ed. 111113 Nichols WL Bowie EJW Rochester, MN Mayo Foundation
Palareti G & Coccheri S (1989) Lowered antithrombin III activity and other clotting changes in homocystinuria: effects of pyridoxine-folate regimen. Haemostasis 19, 24S28S
Peek MJ, Nelson-Piercy C, Manning RA, de Swiet, M Letsky EA (1997) Activated protein C resistance in normal pregnancy. British Journal of Obstetrics and Gynaecology 104, 10841086
Persson BL, Stenberg P, Holmberg L & Astedt B (1980) Transamidating enzymes in maternal plasma and placenta in human pregnancies complicated by intrauterine growth retardation. Journal of Development Physiology 2, 3746
Powers RW, Evans RW, Majors AK, Ojimba JI, Ness RB, Crombleholme WR & Roberts JM (1998) Plasma homocysteine concentration is increased in pre-eclampsia and is associated with evidence of endothelial activation. American Journal of Obstetrics and Gynecology 179, 16051611
Powers RW, Minich LA, Lykins DL, Ness RB, Crombleholme WR & Roberts JM (1999) Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to pre-eclampsia. Journal of the Society for Gynecologic Investigation 6, 7479
Preston FE, Rosendaal FR, Walker ID, Briët D, Brentorp E, Conrad J, Fontcuberta J, Makris M, Mariani G, Noteboom W, Pabinger I, Legnani C, Scharrer I, Schulman S, van der & Meer FJM (1996) Increased fetal loss in women with heritable thrombophilia. Lancet 348, 913916
Public Health Services, Centre for Disease Control and Prevention (1992) Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. Morbidity and Mortality Weekly Report 41, 17
Quèrè I, Bellart H, Hoffet M, Janbon C, Mares P & Gris J (1998) A woman with five consecutive fetal deaths: case report and retrospective analysis of hyperhomocysteinemia prevalence in 100 consecutive women with recurrent miscarriages. Fertility and Sterility 69, 152154
Quinlivan EP, McPartlin J, McNulty H, Ward M, Strain JJ, Weir DG & Scott JM (2002) Importance of both folic acid and vitamin B 12 in reduction of risk of vascular disease. Lancet 359, 227228
Quinlivan EP, McPartlin J, Weir DG & Scott JM (2000) Decreased serum homocysteine in pregnancy: possible role in methylation cycle regulation. Proceedings of the Nutrition Society 59 96A
Rai R, Cohen H, Dave M & Regan L (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospolipid antibodies). British Medial Journal 314, 253257
Rajkovic A, Catalano PM & Malinow MR (1997) Elevated homocyst(e)ine levels with pre-eclampsia. Obstetrics and Gynecology 90, 168171
Rapaport SI & Rao VM (1995) The tissue factor pathway: how it has become a ‘prima ballerina’. Thrombosis and Haemostasis 74, 717
Ray JG, Langman LJ, Vermeulen MJ, Evrovski J, Yeo EL & Cole DEC (2001) Genetics University of Toronto Thrombophilia Study in Women (GUTTSI): genetic and other risk factor for venous thromboembolism in women. Current Controlled Trials in Cardiovascular Medicine 2, 141149
Ray JG & Laskin CA (1999) Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review. Placenta 20, 519529
Reber G, Amiral J, de Moerloose P (1998) Modified antithrombin III levels during normal pregnancy and relationship with prothrombin fragment F1+2 and thrombin-antithrombin complexes. Thrombosis Research 91, 4547
Refsum H, Helland S & Ueland PM (1985) Radioenzymic determination of homocysteine in plasma and urine. Clinical Chemistry 31, 624628
Rodgers GM & Conn MT (1990) Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood 75, 895901
Rodgers GM & Kane WH (1986) Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. Journal of Clinical Investigation 77, 19091916
Rolschau J, Date J & Kristoffersen K (1979) Folic acid supplement and intrauterine growth. Acta Obstetrica and Gynecologica Scandinavica 58, 343346
Rolschau J, Kristoffersen K, Ulrich M, Grinsted P, Schaumburg E & Foged N (1999) The influence of folic acid supplement on the outcome of pregnancies in the county of Funen in Denmark. Part I. European Journal of Obstetrics and Gynecology and Reproductive Biology 87, 105110
Rosendaal FR (1999) Venous thrombosis: a multicausal disease. Lancet 353, 11671173
Salomon O, Steinberg DM, Zivelin A, Gitel S, Dardik R, Rosenberg N, Berliner S, Inbal A, Many A, Lubetsky A, Varon D, Martinowitz U & Seligsohn U (1999) Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Arteriosclerosis, Thrombosis and Vascular Biology 19, 511518
Schlit A, Col-de Beys, C Moriau, M Lavenne-Pardonge E (1996) Acquired activated protein C resistance in pregnancy. Thrombosis Research 84, 203206
Schwagner I & Jungi TW (1994) Effect of human recombinant cytokines on the induction of macrophage procoagulant activity. Blood 83, 152160
Selhub J, Jacques PF, Wilson PWF, Rush D & Rosenbery IH (1993) Vitamin status and intake as primary determinants of homo-cysteinemia in an elderly population. Journal of the American Medical Association 270, 26932698
Sheppard BL & Bonnar J (1999) Uteroplacental hemostasis in intrauterine fetal growth retardation. Seminars in Thrombosis and Hemostasis 25, 443446
Shu H, Wramsby M, Bokarewa M, Blombäck M & Bremme K (2000) Decrease in protein C inhibitor activity and acquired APC resistance during normal pregnancy. Journal of Thrombosis and Thrombolysis 9, 277281
Sikkema JM, Franx A, Bruinse HW, van der, Wijk NJ, de Valk, HW Nikkels PG (2002) Placental pathology in early onset pre-eclampsia and intra-uterine growth restriction in women with and without thrombophilia. Placenta 23, 337342
Simpson EL, Lawrenson RA, Nightingale AL & Farmer RDT (2001) Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. British Journal of Obstetrics and Gynaecology 108, 5660
Somekawa Y, Kobayashi K, Tomura S, Aso T & Hamaguchi H (2002) Effects of hormone replacement therapy and methylene-tetrahydrofolate reductase polymorphism on plasma folate and homocysteine levels in postmenopausal Japanese women. Fertility and Sterility 77, 481486
Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, Finkelstein JD, Blom HJ, Thomas CMG, Borm GF, Wouters MGAJ & Eskes TKAB (1994) Maternal hyperhomocysteinemia: a risk factor for neural-tube defects?. Metabolism 43, 14751480
Stirling Y, Woolf L, North WRS, Seghatchian MJ & Meade TW (1984) Haemostasis in normal pregnancy. Thrombosis and Haemostasis 52, 176182
Thambyrajah J, Landray MJ, Jones HJ, McGlynn FJ, Wheeler DC & Townend JN (2001) A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease. Journal of the American College of Cardiology 37, 18581863
Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC & Townend JN (2000) Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure?. Circulation 102, 871875
Ubbink JB, Becker PJ, Veramaak WJH & Delport R (1995) Results of B-vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine. Clinical Chemistry 41, 10331037
Ubbink JB, Vermaak WJH, van der, Merwe A, Becker PJ, Delport R & Potgieter HC (1994) Vitamin requirements for the treatment of hyperhomocysteinemia in humans. Journal of Nutrition 124, 19271933
Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A & Allen RH (1993) Total homocysteine in plasma or serum: methods and clinical applications. Clinical Chemistry 39, 17641779
Undas A, Domagala TB, Jankowski M & Szczeklik A (1999) Treatment of hyperhomocysteinemia with folic acid and vitamins B 12 and B 6 attenuates thrombin generation. Thrombosis Research 95, 281288
Undas A, Williams EB, Butenas S, Orfeo T & Mann K (2001) Homocysteine inhibits inactivation of factor Va by activated protein C. Journal of Biological Chemistry 276, 43894397
Uszynski M, Zekanowska E, Uszynski W & Kuczynski J (2001) Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism. European Journal of Obstetrics and Gynecology and Reproductive Biology 95, 163166
van Baal, WM Smolders, RGV van der, Mooren MJ, Teerlink T & Kenemans P (1999) Hormone replacement therapy and plasma homocysteine levels. Obstetrics and Gynecology 94, 485491
van den, Berg M, Boers GH, Franken DG, Blom HJ, van Kamp, GJ Jakobs, C Rauwerda, JA Kluft, C Stehouwert CD (1995) Hyperhomocysteinemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. European Journal of Clinical Investigation 25, 176181
van der, Gaag MS, Ubbink JB, Sillanaukee P, Nikkari S & Hendriks HF (2000) Effects of consumption of red wine, spirits, and beer on serum homocysteine. Lancet 355 1522
van der, Molen EF, Verbruggen B, Nováková I, Eskes TKAB, Monnens LAH & Blom HJ (2000) Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy. British Journal of Obstetrics and Gynaecology 107, 785791
van Hinsbergh VWM (2001) The endothelium: vascular control of haemostasis. European Journal of Obstetrics and Gynaecology and Reproductive Biology 95, 198201
van Wersch, JWJ Ubachs JMH (1991) Blood coagulation and fibrinolysis during normal pregnancy. European Journal of Clinical Chemistry and Clinical Biochemistry 29, 4550
van Wersch, JWJ Vooijs, MEEC Ubachs JMH (1997) Coagulation factor XIII in pregnant smokers and non-smokers. International Journal of Clinical and Laboratory Research 27, 6871
Virchow R (1860) Cellular Pathology London Churchill
Vollest SE, Refsum H, Irgens LM, Emblem BM, Tverkal A, Gjessing HK, Monsen ALB & Ueland PM (2000) Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study. American Journal of Clinical Nutrition 71, 962968
von Eckardstein, A Malinow, MR Upson, B Heinrich, J Schulte, H Schonfeld, R Kohler, E Assmann G (1994) Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men. Arteriosclerosis and Thrombosis 14, 460464
Walker MC, Garner PR, Keely EJ, Rock GA & Reis MD (1997) Changes in activated protein C resistance during normal pregnancy. American Journal of Obstetrics and Gynecology 177, 162169
Walker MC, Smith GN, Perkin SL, Keely EJ & Garner PR (1999) Changes in homocysteine levels during normal pregnancy. Obstetrics and Gynecology 180, 660664
Ward M, McNulty H, McPartlin J, Strain JJ, Weir DG & Scott JM (1997) Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid. Quarterly Journal of Medicine 90, 519524
Whitaker AN, McFarlane JR, Rowe EA, Lee K & Masci PP (1985) Measurement of autoantibodies against fibrinogen and fibrin degradation products by enzyme-linked immunoassay. Thrombosis and Haemostasis 53, 8085
Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molloy AM, Weir DG, Shields DC & Scott JM (1995) A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Quarterly Journal of Medicine 88, 763766
Wouters MGAJ, Boers GHJ, Blom HJ, Trijbels FJM, Thomas CMG, Borm GF, Steegers-Theunissen RPM & Eskes TKAB (1993) Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertility and Sterility 60, 820825
Wright D, Poller L, Thomson JM, Sidebotham A, Hirst CF & Hirsch P (1998) A longitudinal study of the factor VII rise during pregnancy. Thrombosis and Haemostasis 79, 328330
Wright JG, Cooper P, Astedt B, Lecander I, Wilde JT, Preston FE & Greaves M (1988) Fibrinolysis during normal human pregnancy: complex inter-relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time. British Journal of Haematology 69, 253258
Yarnell JWG, Sweetnam PM, Rumley A & Lowe GDO (2000) Life-style and hemostatic risk factors for ischemic heart disease–The Caerphilly Study. Arteriosclerosis, Thrombosis and Vascular Biology 20, 271279
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Proceedings of the Nutrition Society
  • ISSN: 0029-6651
  • EISSN: 1475-2719
  • URL: /core/journals/proceedings-of-the-nutrition-society
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 0
Total number of PDF views: 208 *
Loading metrics...

Abstract views

Total abstract views: 165 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 21st November 2017. This data will be updated every 24 hours.